GLP-1 Body Composition Changes What Trials Show About Lean Mass Clinical trials of semaglutide and tirzepatide consistently demonstrate that effective GLP-1 weight loss reduces both fat and lean mass , with fat making up the majority of the loss (DXA substudies)
Should insurance not cover the medication, manufacturer savings programs might offer discounts, and the Klinic team in Martins Ferry, Ohio, can help explore various financial assistance options
However, fibre intake should be increased gradually to prevent excessive bloating, and patients should ensure adequate fluid intake to support digestive function
Zepbound dosage Zepbound is approved for use in adults only
The SURPASS clinical trial program, which evaluated tirzepatide in over 10,000 patients with type 2 diabetes, included cardiovascular safety assessments